6.
de Vries E, Bray F, Coebergh J, Parkin D
. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003; 107(1):119-26.
DOI: 10.1002/ijc.11360.
View
7.
Xiang F, Lucas R, Hales S, Neale R
. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. JAMA Dermatol. 2014; 150(10):1063-71.
DOI: 10.1001/jamadermatol.2014.762.
View
8.
Muntyanu A, Savin E, Ghazawi F, Alakel A, Zubarev A, Litvinov I
. Geographic Variations in Cutaneous Melanoma Distribution in the Russian Federation. Dermatology. 2020; 236(6):500-507.
DOI: 10.1159/000507617.
View
9.
Conte S, Ghazawi F, Le M, Nedjar H, Alakel A, Lagace F
. Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada. Front Med (Lausanne). 2022; 9:830254.
PMC: 8927870.
DOI: 10.3389/fmed.2022.830254.
View
10.
Litvinov I, Xie P, Gunn S, Sasseville D, Lefrancois P
. The transcriptional landscape analysis of basal cell carcinomas reveals novel signalling pathways and actionable targets. Life Sci Alliance. 2021; 4(7).
PMC: 8200290.
DOI: 10.26508/lsa.202000651.
View
11.
Muntyanu A, Ghazawi F, Nedjar H, Rahme E, Alakel A, Zubarev A
. Non-Melanoma Skin Cancer Distribution in the Russian Federation. Dermatology. 2020; 237(6):1007-1015.
DOI: 10.1159/000512454.
View
12.
Lefrancois P, Xie P, Gunn S, Gantchev J, Martinez Villarreal A, Sasseville D
. In silico analyses of the tumor microenvironment highlight tumoral inflammation, a Th2 cytokine shift and a mesenchymal stem cell-like phenotype in advanced in basal cell carcinomas. J Cell Commun Signal. 2020; 14(2):245-254.
PMC: 7272519.
DOI: 10.1007/s12079-020-00563-6.
View
13.
Forsea A, Del Marmol V, de Vries E, Bailey E, Geller A
. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012; 167(5):1124-30.
DOI: 10.1111/j.1365-2133.2012.11125.x.
View
14.
Berman-Rosa M, Logan J, Ghazawi F, Le M, Conte S, Netchiporouk E
. Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada. Dermatology. 2022; 238(6):1006-1017.
PMC: 9677843.
DOI: 10.1159/000524949.
View
15.
Xie P, Lefrancois P, Sasseville D, Parmentier L, Litvinov I
. Analysis of multiple basal cell carcinomas (BCCs) arising in one individual highlights genetic tumor heterogeneity and identifies novel driver mutations. J Cell Commun Signal. 2022; 16(4):633-635.
PMC: 9733736.
DOI: 10.1007/s12079-022-00679-x.
View
16.
Zhou S, Sikorski D, Xu H, Zubarev A, Chergui M, Lagace F
. Defining the Criteria for Reflex Testing for Mutations in Cutaneous Melanoma Patients. Cancers (Basel). 2021; 13(9).
PMC: 8126223.
DOI: 10.3390/cancers13092282.
View